Ansboro S - Search Results

1

Strategies for improved targeting of therapeutic cells: implications for tissue repair.

Ansboro S, Greiser U, Barry F, Murphy M. Ansboro S, et al. Eur Cell Mater. 2012 Apr 21;23:310-8; discussion 318-9. doi: 10.22203/ecm.v023a24. Eur Cell Mater. 2012. PMID: 22522285 Free article. Review.

2

A chondromimetic microsphere for in situ spatially controlled chondrogenic differentiation of human mesenchymal stem cells.

Ansboro S, Hayes JS, Barron V, Browne S, Howard L, Greiser U, Lalor P, Shannon F, Barry FP, Pandit A, Murphy JM. Ansboro S, et al. J Control Release. 2014 Apr 10;179:42-51. doi: 10.1016/j.jconrel.2014.01.023. Epub 2014 Jan 31. J Control Release. 2014. PMID: 24491910

3

Evaluation of Cartilage Repair by Mesenchymal Stem Cells Seeded on a PEOT/PBT Scaffold in an Osteochondral Defect.

Barron V, Merghani K, Shaw G, Coleman CM, Hayes JS, Ansboro S, Manian A, O'Malley G, Connolly E, Nandakumar A, van Blitterswijk CA, Habibovic P, Moroni L, Shannon F, Murphy JM, Barry F. Barron V, et al. Among authors: ansboro s. Ann Biomed Eng. 2015 Sep;43(9):2069-82. doi: 10.1007/s10439-015-1246-2. Epub 2015 Jan 15. Ann Biomed Eng. 2015. PMID: 25589372

4

Evaluation of the Early In Vivo Response of a Functionally Graded Macroporous Scaffold in an Osteochondral Defect in a Rabbit Model.

Barron V, Neary M, Mohamed KM, Ansboro S, Shaw G, O'Malley G, Rooney N, Barry F, Murphy M. Barron V, et al. Among authors: ansboro s. Ann Biomed Eng. 2016 May;44(5):1832-44. doi: 10.1007/s10439-015-1473-6. Epub 2015 Oct 5. Ann Biomed Eng. 2016. PMID: 26438451

5

Mesenchymal stem cells for the management of rheumatoid arthritis: immune modulation, repair or both?

Ansboro S, Roelofs AJ, De Bari C. Ansboro S, et al. Curr Opin Rheumatol. 2017 Mar;29(2):201-207. doi: 10.1097/BOR.0000000000000370. Curr Opin Rheumatol. 2017. PMID: 27941390 Review.

6

Joint morphogenetic cells in the adult mammalian synovium.

Roelofs AJ, Zupan J, Riemen AHK, Kania K, Ansboro S, White N, Clark SM, De Bari C. Roelofs AJ, et al. Among authors: ansboro s. Nat Commun. 2017 May 16;8:15040. doi: 10.1038/ncomms15040. Nat Commun. 2017. PMID: 28508891 Free PMC article.

7

Targeting bioenergetics prevents CD4 T cell-mediated activation of synovial fibroblasts in rheumatoid arthritis.

Petrasca A, Phelan JJ, Ansboro S, Veale DJ, Fearon U, Fletcher JM. Petrasca A, et al. Among authors: ansboro s. Rheumatology (Oxford). 2020 Oct 1;59(10):2816-2828. doi: 10.1093/rheumatology/kez682. Rheumatology (Oxford). 2020. PMID: 32047926

8

STAT3 Mediates the Differential Effects of Oncostatin M and TNFα on RA Synovial Fibroblast and Endothelial Cell Function.

Hanlon MM, Rakovich T, Cunningham CC, Ansboro S, Veale DJ, Fearon U, McGarry T. Hanlon MM, et al. Among authors: ansboro s. Front Immunol. 2019 Aug 28;10:2056. doi: 10.3389/fimmu.2019.02056. eCollection 2019. Front Immunol. 2019. PMID: 31555281 Free PMC article.

9

A new class of 7-deazaguanine agents targeting autoimmune diseases: dramatic reduction of synovial fibroblast IL-6 production from human rheumatoid arthritis patients and improved performance against murine experimental autoimmune encephalomyelitis.

Cotter M, Quinn SM, Fearon U, Ansboro S, Rakovic T, Southern JM, Kelly VP, Connon SJ. Cotter M, et al. Among authors: ansboro s. RSC Med Chem. 2024 Mar 28;15(5):1556-1564. doi: 10.1039/d4md00028e. eCollection 2024 May 22. RSC Med Chem. 2024. PMID: 38784475 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page